UMN Pharma Inc.

UMN Pharma Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY52.29
Market Cap
JPY4.83 B
Shares Outstanding
15.3 M
Public Float
11.73 M

Profile

Address
4-2-3 Gosyonoyumoto
Akita Akita 010
Japan
Employees -
Website http://www.umnpharma.com
Updated 07/08/2019
UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, and rotavirus. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan.

Financials

View All
Created with Highcharts 5.0.14UMN Pharma Inc.Net Income. Fiscal year is January-December. All values JPY Millions.3 7173 7173 9613 9613 3903 3908 3448 34415915972972920132014201520162017201802k4k6k8k10k
Created with Highcharts 5.0.14UMN Pharma Inc.Sales/Revenue. Fiscal year is January-December. All values JPY Millions.93931 1091 1092032035353104104104104201320142015201620172018025050075010001250

Tatsuyoshi Hirano
Chairman & President
Hiroyuki Hashimoto
Director & Manager-Finance